Generic Name and Formulations:
Diclofenac sodium 3%; gel; contains benzyl alcohol.
Indications for SOLARAZE:
Use lowest effective dose for shortest duration. Apply to lesions twice daily for 60–90 days.
Coronary artery bypass graft surgery.
Risk of serious cardiovascular events.
Increased risk of serious cardiovascular events (including MI, stroke). Avoid in recent MI, severe heart failure; if necessary, monitor. History of ulcer disease and/or GI bleeding. Severe renal or hepatic impairment. Avoid sun and UV light. Aspirin allergy. Asthma. Avoid eyes, and open skin wounds, infections, or exfoliative dermatitis. Elderly. Labor & delivery. Pregnancy (Cat.B); avoid in 3rd trimester. Nursing mothers: not recommended.
Increased risk of GI events with concomitant aspirin or oral NSAIDs. Concomitant other topical medications or products (eg, sunscreens, cosmetics): not studied.
Pruritus, rash, contact dermatitis, dry skin, exfoliation, local pain, paresthesia; cardiovascular thrombotic events, edema, photosensitivity.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses